Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 520

1.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

2.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

3.

Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.

Mukherjee A, Shrivastava S, Bhanja Chowdhury J, Ray R, Ray RB.

J Virol. 2014 Jul;88(14):7929-40. doi: 10.1128/JVI.00787-14. Epub 2014 Apr 30.

4.

Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.

Wang W, Yin Y, Xu L, Su J, Huang F, Wang Y, Boor PPC, Chen K, Wang W, Cao W, Zhou X, Liu P, van der Laan LJW, Kwekkeboom J, Peppelenbosch MP, Pan Q.

Sci Signal. 2017 Apr 25;10(476). pii: eaah4248. doi: 10.1126/scisignal.aah4248.

PMID:
28442624
5.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
6.

Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.

Sung PS, Cheon H, Cho CH, Hong SH, Park DY, Seo HI, Park SH, Yoon SK, Stark GR, Shin EC.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10443-8. doi: 10.1073/pnas.1513341112. Epub 2015 Jul 27.

7.

Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.

He CL, Liu M, Tan ZX, Hu YJ, Zhang QY, Kuang XM, Kong WL, Mao Q.

World J Gastroenterol. 2018 Jan 14;24(2):226-236. doi: 10.3748/wjg.v24.i2.226.

8.

HCV NS5A and IRF9 compete for CypA binding.

Bobardt M, Hopkins S, Baugh J, Chatterji U, Hernandez F, Hiscott J, Sluder A, Lin K, Gallay PA.

J Hepatol. 2013 Jan;58(1):16-23. doi: 10.1016/j.jhep.2012.08.007. Epub 2012 Aug 15.

9.

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.

Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT.

J Hepatol. 2011 Aug;55(2):289-98. doi: 10.1016/j.jhep.2010.11.019. Epub 2010 Dec 13.

10.

Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1.

Ooi EL, Chan ST, Cho NE, Wilkins C, Woodward J, Li M, Kikkawa U, Tellinghuisen T, Gale M Jr, Saito T.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1909-14. doi: 10.1073/pnas.1314268111. Epub 2014 Jan 21.

11.

Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Bandiera S, Pernot S, El Saghire H, Durand SC, Thumann C, Crouchet E, Ye T, Fofana I, Oudot MA, Barths J, Schuster C, Pessaux P, Heim MH, Baumert TF, Zeisel MB.

J Virol. 2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.

12.

IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.

Aboulnasr F, Hazari S, Nayak S, Chandra PK, Panigrahi R, Ferraris P, Chava S, Kurt R, Song K, Dash A, Balart LA, Garry RF, Wu T, Dash S.

PLoS One. 2015 Dec 11;10(12):e0141655. doi: 10.1371/journal.pone.0141655. eCollection 2015.

13.

Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.

Zhao LJ, He SF, Liu Y, Zhao P, Bian ZQ, Qi ZT.

Cell Physiol Biochem. 2016;40(1-2):77-90. Epub 2016 Nov 18.

14.

IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment.

Sehgal M, Zeremski M, Talal AH, Ginwala R, Elrod E, Grakoui A, Li QG, Philip R, Khan ZK, Jain P.

J Interferon Cytokine Res. 2015 Sep;35(9):698-709. doi: 10.1089/jir.2014.0211. Epub 2015 Jun 19.

15.

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.

Zhang Q, Wang Y, Wei L, Jiang D, Wang JH, Rao HY, Zhu L, Chen H, Fei R, Cong X.

J Gastroenterol Hepatol. 2008 Nov;23(11):1747-61. Epub 2007 Jun 7.

PMID:
17559358
16.

MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.

Yang D, Meng X, Xue B, Liu N, Wang X, Zhu H.

PLoS One. 2014 Apr 11;9(4):e94501. doi: 10.1371/journal.pone.0094501. eCollection 2014.

17.
18.

CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.

Ye L, Wang X, Wang S, Wang Y, Song L, Hou W, Zhou L, Li H, Ho W.

Hepatology. 2009 Mar;49(3):753-62. doi: 10.1002/hep.22715.

19.

Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.

Sarma NJ, Tiriveedhi V, Crippin JS, Chapman WC, Mohanakumar T.

J Virol. 2014 Apr;88(7):3733-43. doi: 10.1128/JVI.03060-13. Epub 2014 Jan 15.

20.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

Supplemental Content

Support Center